DOI QR코드

DOI QR Code

In vitro Adipocyte Differentiation Inhibition and in vivo Effects on Lipid Metabolism in High-Fat Diet-Induced Obesity of Euphorbia humifusa

  • Sung-Gyu Lee (Department of Medical Laboratory Science, College of Health Science, Dankook University) ;
  • Hyun Kang (Department of Medical Laboratory Science, College of Health Science, Dankook University)
  • 투고 : 2023.08.04
  • 심사 : 2023.10.30
  • 발행 : 2024.02.28

초록

Euphorbia humifusa Willd (Euphorbiaceae) is a functional raw material with various pharmacological activities. This study aimed to validate the inhibitory effect of Euphorbia humifusa extract (EHE) on adipocyte differentiation in vitro and in a high-fat-diet (HFD)-induced mouse model to evaluate the E.a humifusa as a novel anti-obesity and lipid metabolism enhancer agent. EHE effects on obesity and lipid metabolism were assessed in HFD-induced obese mice after 4-week treatments. Results were compared among four treatment groups (n = 7/group): low fat diet (LFD), high fat diet (HFD), and HFD-induced obese mice treated with either 100 or 200 mg/kg/day EHE (EHE100 and EHE200, respectively). EHE (50 to 200 ㎍/ml) and quercetin (50 ㎍/ml) significantly reduced 3T3-L1 preadipocyte differentiation (p < 0.001), in a concentration-dependent manner. EHE affected lipid metabolism, as evidenced by changes in serum lipid components. The HFD-EHE100 and HFD-EHE200 groups exhibited significantly (p < 0.05) reduced triglycerides (TG, 97.50 ± 6.56 and 82.50 ± 13.20 mg/dL, respectively) and low-density lipoprotein-cholesterol (LDL-c: 40.25 ± 4.99 and 41.25 ± 6.36 mg/dL, respectively) compared to the HFD group (TG: 129.25 ± 19.81 mg/dL; LDL-c: 51.75 ± 11.59 mg/dL). Haematoxylin and Eosin (H&E) and Oil red O staining showed that EHE markedly reduced lipid accumulation and inhibited lipogenesis in the liver. Interestingly, EHE significantly (p < 0.01) reduced the expression of adipogenic transcription factors in liver tissue. Our results indicated that EHE has the potential to be a therapeutic agent for addressing obesity and lipid metabolism.

키워드

과제정보

This work has supported by a National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIT) (No. 2021R1F1A1063617).

참고문헌

  1. Park YM, Oh HG, Kang YG, Kim YP, Sin HS, Jang SH, et al. 2015. Anti-obesity effects of lactic acid bacteria-fermented Dioscoreae rhizoma powder on high fat diet-fed animal model. J. Physiol. Pathol. Korean Med. 29: 267-272. https://doi.org/10.15188/kjopp.2015.06.29.3.267
  2. Lee JH. 1992. Treatment of obesity. J. Korean Soc. Food Sci. Nutr. 1: 21-24.
  3. Kim KI, Han CK, Seong KS, Lee OH, Park JM, Lee BY. 2003. Effect of whole powder and extracts of Gastrodiae Rhizoma on serum lipids and body fat in rats fed high-fat diet. Korean J. Food Sci. Technol. 35: 720-725.
  4. Apfelbaum M, Vague P, Ziegler O, IIanotin C, Thomas F, Leutenegger E. 1999. Long-term maintenance of weight loss after a very low calorie diet: efficacy and tolerability of sibutramine. Am. J. Med. 106: 179-184. https://doi.org/10.1016/S0002-9343(98)00411-2
  5. Yum KS. 2001. Orlistat (XenicalR). Korean J. Obes. 10: 25-36.
  6. Manna P and Jain SK. 2015. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab. Syndr. Relat. Disord. 13: 423-444. https://doi.org/10.1089/met.2015.0095
  7. Kim NY, Lee JM, Lee JY, Lee HY. 2016. Enhancement of anti-obesity activities of Aronia melanocarpa Elliot extracts from low temperature ultrasonification process. Korean J. Med. Crop Sci. 24: 309-316. https://doi.org/10.7783/KJMCS.2016.24.4.309
  8. Maingrette F and Renier G. 2003. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes 52: 2121-2128. https://doi.org/10.2337/diabetes.52.8.2121
  9. German AJ, Ryan VH, German AC, Wood IS, Trayhurn P. 2010. Obesity, its associated disorders and the role of inflammatory adipokines in companion animals. Vet. J. 185: 4-9. https://doi.org/10.1016/j.tvjl.2010.04.004
  10. Jin KS, Lee SH, Kwon HJ, Kim BW. 2017. Anti-obesity effect of Salsola collina ethanol extract. J. Life Sci. 27: 888-895.
  11. Tsai SC, Huang YW, Wu CC, Wang JJ, Chen YT, Singhania RR, et al. 2022. Anti-Obesity Effect of Nostoc commune Ethanol Extract In Vitro and In Vivo. Nutrients 14: 968.
  12. Choi MY. 2010. Antibacterial activity of Euphorbia humifusa extracts on food-borne pathogenic bacteria. Korean J. Community Living Sci. 2: 13-18.
  13. Heo SI, Hu W, Han W, Wang MH. 2008. Antioxidant activity and cytotoxic effect of extracts from Euphorbia humifusa. Kor. J. Pharmacogn. 39: 295-299.
  14. An DH, Cho SJ, Jung ES, Lee HJ, Hwang JH, Park EJ, et al. 2006. Antioxidant and anticancer activities of water extracts from Ceramium kondoi. J. Korean Soc. Food Sci. Nutr. 35: 1304-1308. https://doi.org/10.3746/jkfn.2006.35.10.1304
  15. Kim SY, Won DH, Lim MS, Park SN. 2010. Cellular protective effect and component analysis of Euphorbia humifusa extracts. Kor. J. Pharmacogn. 41: 264-269.
  16. Lee SJ, Kim EK, Hwang JW, et al. 2009. Free radical scavenging activity of β-chitooligosaccharides. J. Chitin Chitosan. 14: 24-28.
  17. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-942.
  18. Katja Z, Valerie V, Martin W Matthias B. 2012. Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal. Biochem. 425: 88-90. https://doi.org/10.1016/j.ab.2012.03.005
  19. Tak YJ, Lee YS, Lee JS, Kang JH. 2004. The treand of obesity-related researches in Korea: from 1984 to 2002. Korean J. Obes. 13: 1-13.
  20. Kim SH, Kim JY, Ryu KA, Sohn CM. 2007. Evaluation of the dietary diversity and nutrient intakes in obese adults. Korean J. Community Nutr. 12: 583-591.
  21. Liu F, Kim J, Li Y, Liu X, Li J, Chen X. 2001. An extract of Lagerstroemia speciosa L. has insulin-like uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr. 131: 2242-2247. https://doi.org/10.1093/jn/131.9.2242
  22. Que F, Mao L, Zhu C, Xie G. 2006. Antioxidant properties of Chinese yellow wine, its concentrate and volatiles. LWT 39: 111-117. https://doi.org/10.1016/j.lwt.2005.01.001
  23. Hsu CL and Yen GC. 2006. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. Mol. Nutr. Food Res. 50: 1072-1079. https://doi.org/10.1002/mnfr.200600040
  24. Ahn J, Lee H, Kim S, Park J, Ha T. 2008. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 373: 545-549. https://doi.org/10.1016/j.bbrc.2008.06.077
  25. Yang JY, Della-Fera MA, Rayalam S, Ambati S, Hartzell DL, Park HJ, et al. 2008. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82: 1032-1039. https://doi.org/10.1016/j.lfs.2008.03.003
  26. Lsselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL. 2006. Harrison's principles of internal medicine. Seoul: MIP 1554-1563.
  27. Cho YS, Shon MY, Lee MK. 2007. Lipid-lowering action of powder and water extract of mulberry leaves in C57BL/6 mice fed high-fat diet. J. Korean Soc. Food Sci. Nutr. 36: 405-410. https://doi.org/10.3746/jkfn.2007.36.4.405
  28. Freeman BA, Crapo JD. 1982. Biology of disease free radicals and tissue injury. Lab. Invest. 47: 412-426.
  29. Foufelle F, Ferre P. 2002. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366: 377-339.
  30. Inoue M, Ohtake T, Motomura W. 2005. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem. Biophys. Res. Commun. 336: 215-222. https://doi.org/10.1016/j.bbrc.2005.08.070
  31. Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. 2011. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J. Adv. Pharm. Technol. Res. 2: 236-240.  https://doi.org/10.4103/2231-4040.90879